Effectiveness and Cost of Weekly Recombinant Tissue Plasminogen Activator Hemodialysis Catheter Locking Solution

BACKGROUND AND OBJECTIVES: Evidence to guide hemodialysis catheter locking solutions is limited. We aimed to assess effectiveness and cost of recombinant tissue plasminogen activator (rt-PA) once per week as a locking solution, compared with thrice weekly citrate or heparin, in patients at high risk...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin J Am Soc Nephrol
Huvudupphovsmän: Hemmelgarn, Brenda R., Manns, Braden J., Soroka, Steven D., Levin, Adeera, MacRae, Jennifer, Tennankore, Karthik, Wilson, Jo-Anne S., Weaver, Robert G., Ravani, Pietro, Quinn, Robert R., Tonelli, Marcello, Kiaii, Mercedeh, Mossop, Paula, Scott-Douglas, Nairne
Materialtyp: Artigo
Språk:Inglês
Publicerad: American Society of Nephrology 2018
Ämnen:
Original Articles
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5967673/
https://ncbi.nlm.nih.gov/pubmed/29335321
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2215/CJN.08510817
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk